The Chemours Company reported a net loss of $29 million, or 19 cents per share, for Q1 2026, compared to a net loss of $5 million, or 3 cents per share, in the same quarter last year. First-quarter net sales were $1,381 million, reflecting a 1% year-over-year increase, but falling short of the Zacks Consensus Estimate of $1,402.6 million.
Adjusted EBITDA rose 2% to $169 million, driven by higher pricing and favorable currency impacts. Key segment performances included Titanium Technologies with revenues of $559 million, down 6% from last year, and Thermal & Specialized Solutions, which saw a 22% increase to $568 million. Advanced Performance Materials revenues fell 17% to $243 million, primarily due to a decrease in volume.
The company anticipates a 15-20% sequential increase in net sales for Q2 2026, with adjusted EBITDA projected between $220-$250 million. For the full year, Chemours expects net sales growth of 3-5% and adjusted EBITDA in the range of $800-$900 million.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
